A detailed history of Commonwealth Equity Services, LLC transactions in Axonics, Inc. stock. As of the latest transaction made, Commonwealth Equity Services, LLC holds 3,082 shares of AXNX stock, worth $212,349. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,082
Previous 3,007 2.49%
Holding current value
$212,349
Previous $207,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

BUY
$66.47 - $69.65 $4,985 - $5,223
75 Added 2.49%
3,082 $207,000
Q1 2024

Apr 29, 2024

BUY
$56.67 - $69.36 $170,406 - $208,565
3,007 New
3,007 $207,000
Q3 2023

Oct 23, 2023

BUY
$48.64 - $62.51 $199,715 - $256,666
4,106 New
4,106 $230,000
Q4 2022

Feb 07, 2023

BUY
$59.56 - $76.6 $5,717 - $7,353
96 Added 2.73%
3,617 $226,000
Q3 2022

Nov 14, 2022

BUY
$57.96 - $78.12 $204,077 - $275,060
3,521 New
3,521 $248,000
Q2 2022

Jul 19, 2022

SELL
$39.5 - $64.42 $135,682 - $221,282
-3,435 Closed
0 $0
Q1 2022

May 04, 2022

BUY
$43.74 - $62.76 $150,246 - $215,580
3,435 New
3,435 $215,000
Q4 2021

Jan 31, 2022

SELL
$50.01 - $73.35 $582,366 - $854,160
-11,645 Closed
0 $0
Q3 2021

Oct 29, 2021

BUY
$59.21 - $78.66 $689,500 - $915,995
11,645 New
11,645 $757,000
Q2 2021

Aug 11, 2021

SELL
$51.39 - $66.9 $204,737 - $266,529
-3,984 Closed
0 $0
Q1 2021

May 04, 2021

BUY
$49.14 - $59.89 $195,773 - $238,601
3,984 New
3,984 $238,000
Q4 2020

Feb 11, 2021

SELL
$42.19 - $51.5 $634,832 - $774,920
-15,047 Closed
0 $0
Q3 2020

Nov 05, 2020

BUY
$35.33 - $51.04 $11,800 - $17,047
334 Added 2.27%
15,047 $768,000
Q2 2020

Aug 12, 2020

BUY
$22.91 - $39.83 $337,074 - $586,018
14,713 New
14,713 $516,000

Others Institutions Holding AXNX

About Axonics, Inc.


  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.38B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Commonwealth Equity Services, LLC Portfolio

Follow Commonwealth Equity Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.